As a physician, Kristen has seen both tragedies and miracles in her career. As a caregiver and human, she has personally survived the loss of three family members, two to cancer. Now serving as Senior Vice President of Early Clinical Development, Hematology/Oncology & Cell Therapy at Bristol Myers Squibb (BMS), she and her team investigate new ways to transform patients’ lives through science on a daily basis. In this session, we will learn why patients are at the core of everything Kristen and her team do at BMS and hear how unique patient perspectives are helping to inform scientific discoveries. We will leave this session with a renewed understanding of the power of innovative medicines to profoundly change the course of serious human diseases, as well as BMS’ commitment to increase access and involve patients in improving care.
In the last decade, immuno-oncology treatments have transformed cancer care and brought new hope to millions of cancer patients. By harnessing the power of each person’s own immune system, immunotherapy has created new treatment options distinctly different from traditional methods. In this session, we will learn what immunotherapy is, how it works and where research is headed for the future. We will leave this session with a better understanding of immunotherapy, including vocabulary to discuss this treatment option with your oncologist.
Caregivers are undercounted, unheard, and all but invisible. They often sacrifice their health, deal with emotional isolation and lack time to care for themselves. This issue is compounded when a caregiver is a woman or a racial/ethnic minority due to the inherent inequities in our economic system and pressure from traditional family paradigms. In this session, we will discuss how we, as a society and individuals, can support caregivers to address their emotional and physical needs and create systems where we proactively help the helpers.
Clinical trials are more than a last resort option. Clinical trials are the future of medicine. Across cancer stages and types, there are trials out there for everyone. In this session, we will learn how to find clinical trials and their requirements. We will leave this session with a greater understanding of clinical trials, the kinds of trials out there for patients, and how they positively affect the future of healthcare.
Your genetic make-up and the genetic make-up of your cancer are the biggest determinants of cancer risk, the treatment you receive, and the effectiveness of that treatment. It has never been more important to understand the role that genetics plays in cancer diagnosis, treatment, and survivorship. In this session, a panel of experts will answer your questions and explain the different ways genetics plays a factor in cancer in a patient-friendly way. We will leave this session with a better understanding of the impact of genetics in cancer and what it means for you and your family.
Stage IV or metastatic cancer patients live with their disease, stuck in a time where they can’t celebrate the “survivorship” part of a cancer timeline. In this session, we will hear from folks with years of experience in the metastatic cancer community. We will leave this session with a greater understanding of how to interact with metastatic cancer patients in a way they want you to.
Masks. Susceptibility to viruses. Cancer survivors have lived through their traumatic times of health vulnerability. Now - throw a global pandemic layer on top of that. In this session, we will learn how cancer survivors should navigate the world with a virus that is not likely to disappear. We will leave this session with actionable tips cancer survivors and caregivers can utilize in their own lives to maintain a state of health well-being.
Founder of The Chris Draft Family Foundation in 2006, Chris’ mission is to empower families to lead healthy lifestyles. Four years later, a cancer diagnosis rocked his world when his wife, Keasha, was diagnosed with Stage IV lung cancer. In 2011, Chris and Keasha co-founded Team Draft, a national campaign to change the face of lung cancer. Carrying on her legacy to increase awareness of misconceptions and health disparities, Chris will discuss what advocacy looks like, what it means to hold perspective, and how we can challenge the inequalities in our medical community.